CGT Milestones

top of page

Search

Global CGT Landscape: Q2 2025 Report Highlights

Global CGT Landscape: Q2 2025 Report Highlights

Global CGT Landscape: Q2 2025 Report Highlights

Published by ASGCT & Citeline The ASGCT Q2 2025 report shows sustained CGT momentum with new approvals in gene and mRNA therapies, steady deal activity, and rising oncology focus. M&A volume increased sharply, led by major pharma consolidations in advanced therapies. 👉 Read the full report: ASGCT Gene, Cell, & RNA Therapy Landscape Report Q2 2025 Disclaimer Images used are for illustrative purposes only and do not depict actual persons, products, or facilities. For full deta

Oct 15

Paper cutout illustration of a liver with molecular and pharmaceutical symbols representing metabolic liver therapy.

Paper cutout illustration of a liver with molecular and pharmaceutical symbols representing metabolic liver therapy.

Novo Nordisk to Acquire Akero Therapeutics for $5.2B

Published on LinkedIn (via Spencer Knight) Novo Nordisk has announced its plan to acquire Akero Therapeutics for up to $5.2 billion,...

Oct 12

Futuristic illustration of RNA strands and CAR T cells merging through nanoparticles, representing in vivo therapy innovation.

Futuristic illustration of RNA strands and CAR T cells merging through nanoparticles, representing in vivo therapy innovation.

Bristol Myers Squibb Acquires Orbital Therapeutics for $1.5B

Published on LinkedIn (via Spencer Knight) Bristol Myers Squibb announced a $1.5 billion acquisition of Orbital Therapeutics, advancing...

Oct 12

Illustration of a bladder with a glowing drug-releasing system delivering treatment locally.

Illustration of a bladder with a glowing drug-releasing system delivering treatment locally.

FDA Approves INLEXZO™, the First Drug-Releasing System for Bladder Cancer

Published on LinkedIn (via Spencer Knight) The FDA has approved INLEXZO™ (gemcitabine intravesical system) from Johnson & Johnson,...

Oct 12

Illustration of engineered CAR T cells attacking a solid tumor with glowing immune energy.

Illustration of engineered CAR T cells attacking a solid tumor with glowing immune energy.

Next-Generation CAR T Cells Overcome Solid Tumor Barriers

Published on Technology Networks Researchers at USC Norris and City of Hope engineered CAR T cells that deliver IL-12 fused to a PD-L1...

Oct 4

Abstract illustration of a DNA helix with glowing neurons, symbolizing gene therapy for Parkinson’s disease.

Abstract illustration of a DNA helix with glowing neurons, symbolizing gene therapy for Parkinson’s disease.

AskBio Begins Phase II Gene Therapy Trial for Parkinson’s in Europe

Published on Bayer Bayer’s AskBio has randomized the first European participants in its Phase II trial of AB-1005, an investigational...

Oct 4

Illustration of a Parkinson’s patient with glowing neurons and stem cells integrating into the brain.

Illustration of a Parkinson’s patient with glowing neurons and stem cells integrating into the brain.

First Parkinson’s Patient Dosed in Pivotal Phase III Cell Therapy Trial

Published on BlueRock Therapeutics BlueRock Therapeutics has treated the first Parkinson’s disease patient in its pivotal Phase III trial...

Oct 4

Infographic-style DNA illustration with child and immune cell icons representing Zolgensma and Yescarta as early CGT blockbuster therapies.

Infographic-style DNA illustration with child and immune cell icons representing Zolgensma and Yescarta as early CGT blockbuster therapies.

First-Generation Cell and Gene Therapy Blockbusters: Zolgensma and Yescarta

Published on Alliance for Regenerative Medicine (LinkedIn) Two landmark therapies, Zolgensma and Yescarta, highlight how cell and gene...

Oct 1

FDA Approves First Oral SERD Therapy for Resistant Breast Cancer

FDA Approves First Oral SERD Therapy for Resistant Breast Cancer

FDA Approves First Oral SERD Therapy for Resistant Breast Cancer

Published on LinkedIn (via Spencer Knight) The FDA has approved Inliruqo™ (imlunestrant) from Eli Lilly, the first oral estrogen receptor...

Regulatory & Compliance

Oct 1

Abstract illustration of stem cells surrounding a blood vessel, symbolizing regeneration in kidney disease.

Abstract illustration of stem cells surrounding a blood vessel, symbolizing regeneration in kidney disease.

Stem Cells May Improve Dialysis Access for Kidney Disease Patients

Published on Mayo Clinic News Network Mayo Clinic researchers report that fat-derived mesenchymal stem cells can help prevent vein...

Oct 1

Illustration of a patient walking with glowing neurons in the background, symbolizing gene therapy slowing Huntington’s disease.

Illustration of a patient walking with glowing neurons in the background, symbolizing gene therapy slowing Huntington’s disease.

New Gene Therapy Slows Huntington’s Disease by 75%

Published on Sky News A breakthrough gene therapy called AMT-130 has slowed progression of Huntington’s disease by as much as 75% in a...

Oct 1

Paper cut-out style illustration of a kidney with layered cells, symbolizing lab-grown kidney assembloids with real function.

Paper cut-out style illustration of a kidney with layered cells, symbolizing lab-grown kidney assembloids with real function.

Lab-Grown Kidney Assembloids Show Real Function

Published on Drug Target Review USC Stem Cell scientists have created kidney assembloids that function like real organs, combining...

Sep 24

Business handshake with green-gold financial charts and obesity drug graphics symbolizing Pfizer’s acquisition of Metsera.

Business handshake with green-gold financial charts and obesity drug graphics symbolizing Pfizer’s acquisition of Metsera.

Pfizer to Acquire Metsera in $4.9B Deal Expanding Obesity Pipeline

Published on LinkedIn (via Spencer Knight) Pfizer announced plans to acquire Metsera for up to $4.9B, adding GLP-1 and amylin-based...

Sep 23

Business handshake with a glowing liver graphic and green-gold financial charts symbolizing Roche’s acquisition of 89bio.

Business handshake with a glowing liver graphic and green-gold financial charts symbolizing Roche’s acquisition of 89bio.

Roche to Acquire 89bio in $3.5B Deal Expanding Liver Disease Portfolio

Published on LinkedIn (via Spencer Knight) Roche announced a $3.5B acquisition of 89bio, adding pegozafermin, a late-stage therapy for...

Sep 19

A rising stock market chart with neurons and molecules in the background, vibrant green and gold tones symbolizing financial growth and biotech innovation, no logos, no text

A rising stock market chart with neurons and molecules in the background, vibrant green and gold tones symbolizing financial growth and biotech innovation, no logos, no text

LB Pharmaceuticals Raises $285M in Landmark Biotech IPO

Published on LinkedIn (via Spencer Knight) LB Pharmaceuticals completed the largest biotech IPO of 2025 to date, raising $285M to advance...

Sep 13

Business handshake overlaid with cardiovascular imagery, symbolizing Novartis’ acquisition of Tourmaline Bio.

Business handshake overlaid with cardiovascular imagery, symbolizing Novartis’ acquisition of Tourmaline Bio.

Novartis Acquires Tourmaline Bio in $1.4B Deal to Strengthen Cardiovascular Portfolio

Published on LinkedIn (via Spencer Knight) Novartis has announced its $1.4 billion acquisition of Tourmaline Bio, a New York–based...

Sep 11

An infographic-style chart symbolizing the rapid growth of the global cell and gene therapy market.

An infographic-style chart symbolizing the rapid growth of the global cell and gene therapy market.

Cell and Gene Therapy Market Poised for Blockbuster Growth

Published by Alliance for Regenerative Medicine The cell and gene therapy sector is rapidly expanding, with two blockbuster products...

Sep 7

A glowing stem cell radiating branching light pathways, symbolizing Sarawak’s first stem cell transplant milestone.

A glowing stem cell radiating branching light pathways, symbolizing Sarawak’s first stem cell transplant milestone.

Sarawak General Hospital Completes First Stem Cell Transplant

Published on: See Hua Daily News (诗华日报) Sarawak Central Hospital has successfully performed the state’s first stem cell transplant,...

Malaysia CGT Updates

Aug 29

Abstract illustration of glowing shield over lungs, symbolizing EU approval of immunotherapy for lung cancer.

Abstract illustration of glowing shield over lungs, symbolizing EU approval of immunotherapy for lung cancer.

EU Approves TEVIMBRA for Perioperative Lung Cancer

Published on: LinkedIn (Spencer Knight) The European Commission has approved TEVIMBRA (tislelizumab) from BeOne Medicines, the first PD-1...

Regulatory & Compliance

Aug 28

A young girl smiling with her mother in the rain, symbolizing restored hearing through gene therapy.

A young girl smiling with her mother in the rain, symbolizing restored hearing through gene therapy.

Gene Therapy Restores Hearing in Deaf Children and Adults

Published on: LinkedIn (Spencer Knight) Scientists at Karolinska Institutet have reported a breakthrough gene therapy that restored...

Aug 26

bottom of page